PsyMuKB

PPI network (data source: BioGrid)

A gene is determined as “expressed” when its expression values are above the pre-determined cutoff, which is the mean normalized expression(base 2 log of (TPM+1)) +1 in all brain tissue from GTEx v7 or BrainSpan data.

A protein is determined as “expressed” when its expression values are above the pre-determined cutoff, which is the normalized expression (base 10 log of iBAQ intensity) ≥0.5 in at least one brain tissue from ProteomicsDB data. Otherwise, a gene or protein is determined as either with below-cutoff expressions or no available data.

	The queried gene/protein
	The interacting partner is expressed at mRNA-level
	The interacting partner is expressed at protein-level
	The interacting partner is expressed at both mRNA and protein level
	The interacting partner is with either below-cutoff expressions or no expression data at both mRNA and protein level
	The interacting partner is hit by coding DNMs
	Physical interaction between queried gene/protein and its partner
	Physical interaction between two interacting partners

Symbol A	GeneA coding DNM count	Symbol B	GeneB coding DNM count	Interaction detection method	Publication	Evidence
VEZT	0	CTNNA1	7	affinity chromatography technology	Kuessel-Andermann P (2000)	1
CDH1	4	CTNNA1	7	affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, bioid	Kinch MS (1995), Oneyama C (2002), Navarro P (1993), Takahashi K (1997), Schmeiser K (1999), Catimel B (2005), Guo Z (2014)	7
MYO7A	6	MAP2	7	affinity chromatography technology, pull down	Todorov PT (2001), Todorov PT (2001)	2
RIPOR1	8	MYO7A	6	affinity chromatography technology	Boldt K (2016)	1
MYO7A	6	CALM1	0	pull down	Todorov PT (2001)	1
MYO7A	6	CDH1	4	affinity chromatography technology	Kuessel-Andermann P (2000)	1
MYO7A	6	KEAP1	0	two hybrid	Velichkova M (2002)	1
LANCL1	0	MYO7A	6	affinity chromatography technology, affinity chromatography technology	Huttlin EL (2015), Huttlin EL (2017)	2
VEZT	0	CDH1	4	affinity chromatography technology	Kuessel-Andermann P (2000)	1
MYO7A	6	PRKAR1A	4	two hybrid, affinity chromatography technology	Kuessel-Andermann P (2000), Kuessel-Andermann P (2000)	2
CDH1	4	CTNNB1	30	affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, x-ray crystallography, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, fluorescent resonance energy transfe, affinity chromatography technology, affinity chromatography technology, imaging technique, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, bioid	Davies G (2001), Kucerova D (2001), Oyama T (1994), Hazan RB (1997), Kinch MS (1995), Jiang MC (2002), Hazan RB (1998), Bonvini P (2001), Li Y (1998), Wendeler MW (2004), Shibata T (2003), Piedra J (2003), Oneyama C (2002), Navarro P (1993), Takahashi K (1997), Dobrosotskaya IY (2000), Dobrosotskaya IY (2000), Geng L (2000), Shibamoto S (1995), Rao RK (2002), Rao RK (2002), Huber AH (2001), Schmeiser K (1999), Pai R (2008), Tu LC (2007), Tu LC (2007), Smyth D (2012), Xue B (2005), Xue B (2005), Catimel B (2005), Huang Z (2012), Yan HX (2006), Yan HX (2006), Figueiredo J (2013), Ponce E (2014), Ponce E (2014), Ponce E (2014), Ribeiro AS (2013), Pinheiro H (2012), Geng F (2012), Lee HK (2007), Guo Z (2014)	42
USH1C	2	MYO7A	6	pull down	Boeda B (2002)	1
KHDRBS1	1	MYO7A	6	unspecified method	Asbach B (2012)	1
MGMT	1	MYO7A	6	affinity chromatography technology	Niture SK (2005)	1
CTNNB1	30	CTNNA1	7	affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, pull down, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, biochemical, affinity chromatography technology, affinity chromatography technology, pull down	Oyama T (1994), Roe S (1998), Piedra J (2003), Aberle H (1994), Reuver SM (1998), Selbach M (2006), Tian Q (2004), Wan C (2015), Hein MY (2015), Ji H (2009), Ji H (2009)	11
MYO7A	6	CTNNB1	30	affinity chromatography technology	Kuessel-Andermann P (2000)	1
MYO7A	6	CTNNA1	7	affinity chromatography technology	Kuessel-Andermann P (2000)	1
MYO7A	6	VEZT	0	two hybrid, affinity chromatography technology	Kuessel-Andermann P (2000), Kuessel-Andermann P (2000)	2
KEAP1	0	CDH1	4	affinity chromatography technology, affinity chromatography technology, pull down, bioid	Kim WD (2012), Kim WD (2012), Kim WD (2012), Guo Z (2014)	4
VEZT	0	CTNNB1	30	affinity chromatography technology	Kuessel-Andermann P (2000)	1